$GILD Recent Headlines Are the prevailing technicals

New Post Public Reply Private Reply Replies (0) Message Board

Jan 19, 2014 at 3:56 PM

$GILD Recent Headlines

Are the prevailing technicals bullish, or bearish? 11:54 a.m. Jan. 17, 2014 - Michael Ashbaugh
U.S. stocks drop on Goldman, Citi; Nasdaq edges up 4:07 p.m. Jan. 16, 2014 - Laura Mandaro
Nu Skin sinks on China probe; Best Buy hits 6-month low 4:04 p.m. Jan. 16, 2014 - Ben Eisen
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 4:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
Mounting optimism for hepatitis C drug boosts Gilead to lead S&P 500 3:09 p.m. Jan. 16, 2014 - blogs.marketwatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
3 top trades for 2014 6:00 a.m. Dec. 30, 2013 - Jeff Reeves
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - blogs.marketwatch.com
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Saumya Vaishampayan
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:18 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - blogs.marketwatch.com
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 12:23 p.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 6:13 p.m. Oct. 29, 2013 - Wallace Witkowski
Gilead profit up 17% as HIV drugs top sales growth 5:06 p.m. Oct. 29, 2013 - MarketWatch.com

Gilead Is Not Done; There Is Potentially 50% More Upside This Year 5:32 p.m. Jan. 17, 2014 - Seeking Alpha
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
ModernGraham Valuation Of Gilead Sciences 3:06 p.m. Jan. 17, 2014 - Seeking Alpha
All Signs Point To Geron's Imetelstat Being The Holy Grail Of Myeloproliferative Drugs 2:37 p.m. Jan. 17, 2014 - Seeking Alpha
My Five Favorite Bio-Pharma Stocks from the J.P. Morgan Healthcare Conference 1:50 p.m. Jan. 17, 2014 - TheStreet.com
Stocks 2014: Investing for Growth - The Power and Protection of High Compounding Earnings ... 5:10 p.m. Jan. 16, 2014 - GuruFocus.com
Is The Market On Drugs? 1:30 p.m. Jan. 16, 2014 - benzinga.com
Stocks 2014: Investing For Growth - The Power And Protection Of High Compounding Earnings Growth - Part 2 1:19 p.m. Jan. 16, 2014 - Seeking Alpha
Interesting GILD Put And Call Options For February 14th 10:57 a.m. Jan. 16, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Winning Market 8:01 p.m. Jan. 15, 2014 - TheStreet.com
Where to Find Yield 10:20 a.m. Jan. 15, 2014 - Barrons.com
Gilead Sciences Inc Retains Buy Recommendation 9:00 a.m. Jan. 15, 2014 - TheStreet.com
Chart Predicts Top Biotech is About to Break Out 7:06 p.m. Jan. 14, 2014 - InvestorPlace.com
Standard Review for Gilead's Oncology Candidate - Analyst Blog 11:50 a.m. Jan. 14, 2014 - Zacks.com
The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians 10:20 a.m. Jan. 14, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Is the Downturn Serious? 8:09 p.m. Jan. 13, 2014 - TheStreet.com
Biotech Stocks Back On Top, Led By Biogen, Alexion 5:07 p.m. Jan. 13, 2014 - Investors Business Daily
Gilead Sciences Inc (GILD): Today's Featured Drugs Laggard 5:01 p.m. Jan. 13, 2014 - TheStreet.com
Gilead Sciences Becomes #45 Most Shorted S&P 500 Component, Replacing Intuit 3:34 p.m. Jan. 13, 2014 - TheStreet.com
3 Large-Cap Mutual Funds to Anchor Your Portfolio 6:57 a.m. Jan. 13, 2014 - InvestorPlace.com

European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America 1:15 a.m. Jan. 13, 2014 - BusinessWire - BZX
Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13 5:00 p.m. Jan. 10, 2014 - BusinessWire - BZX
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
Health Canada Issues Notice of Compliance for Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 8:30 a.m. Dec. 16, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Warehouse Strike Over Pensions Jolts AGNE Operations

AGNE Feels Heat as Teamsters Strike Over Pensions Damn near thought we'd seen it all, but here we are, bearings rattled by yet another strike at a time when disruption seems to be the tune of the day. Over 255 members of Teamsters Local 633 have locked horns with Associated Grocers Northeast (AGNE) in Pembroke, New Hampshire. It's not about nickel-and-diming over a pay...

AI in Healthcare: Real Results Unveiled at HLTH 2026

Transforming Healthcare with AI The landscape of healthcare is constantly evolving, and this time, we're diving deep into how AI is shaking things up. MCG Health and Telligen, both heavyweights in the health sector, are stepping into the limelight at the HLTH 2026 conference. This ain't just any run-of-the-mill presentation; it's where the rubber meets the road in...

Marini SkinSolutions Wins with Night Zyme Complex

Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...

GAC Hits Record with 223,000 Units Exported in 2026

GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...

Mondego Bio Charges Ahead with Cancer Therapy Trials

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Bram Schot Steers Marelli Through Chapter 11 Resurgence

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Attilio's Longevity Push: Science with a Personal Touch

Reimagining Longevity: Beyond Just Adding Years Guess what? Living longer isn't just about reaching the milestone of blowing out 100 birthday candles. That's the message Attilio drilled home during their recent Longevity Event. And let me tell you, it was quite a doozy—from what went down at Stanford to a deep dive at the Buck Institute, it was an eye-opening affair....

SKF's Industrial Push: Energy Efficiency at COP31

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Dill Dinkers Eyes Next Growth Phase with Local Deal

A Leap Toward Future Growth You know, not every day does a company manage to turn its early beginnings into a robust franchise system, but Dill Dinkers seems to be onto something here. This pickleball outfit is tossing its original Maryland clubs to local hands, and it’s not just a transaction—it’s a calculated play intending to solidify their expansion path...

FirstService Jolts Mira Mar Redesign Masterplan

Sarasota's Mira Mar Finds Its Match Holy smokes! Sarasota's making waves again as Mira Mar, the high-end luxury condominium development, ropes in FirstService Residential to give it that extra oomph. Now, we're talkin’ about a real shake-up in downtown Sarasota real estate. The game here isn’t just grabbing a slice of the pie; it's the whole damn pie. Luxury Living...